15:37 IBD Targets and Monitoring February 10, 2022 • Ulcerative Colitis Content Hub @PlevrisN discusses #IBD #targets and #monitoring.
1:06:11 Common Medical Problems February 7, 2022 • Family Medicine Greg Boss, MD, discusses common #medicalproblems encountered in #familymedicine.
27:51 Muscle Function Assessment in Pompe Disease February 6, 2022 • Pompe Disease Content Hub Jordi Diaz-Manera, MD, PhD, of @jwmdrc, discusses #muscle function and #QoL in #PompeDisease.
22:36 Current State of Knowledge Regarding Pompe Disease February 6, 2022 • Pompe Disease Content Hub John Crowley, of @amicusrx1, discusses current knowledge regarding #PompeDisease.
14:06 Stool Test Options for Gastrointestinal Disorders February 2, 2022 • Gastroenterology Karen Kroeker, MD, of @UAlberta, discusses #gastrointestinal #stool #testing.
24:57 Balancing Toxicity and Response in Ph+ CML Treatment February 2, 2022 • CML Content Hub B Douglas Smith, MD, of @JohnsHopkins, discusses #balance between #toxicity and #response in #CML.
49:27 Best Practices in Transitional Care and IBD Management February 1, 2022 • Ulcerative Colitis Content Hub @MRegueiroMD, Dr Jennifer Dotson, and @JessPhilpottMD discuss transitional care for patients with IBD.
4:35 Safety and Efficacy of Asciminib in Third-Line Treatment for CML January 30, 2022 • CML Content Hub @mjmauroMD, of @MSKCancerCenter, discusses #third-line treatment for #CML.
1:00:50 Rheumatoid Arthritis: An Overview January 25, 2022 • Rheumatoid Arthritis Content Hub @DuncanFMoore, of @MGHrheumatology, provides an overview of #RheumatoidArthritis.
1:14:19 Infectious Diseases and Immunology: TB, Mosquito Pathogens, Antibodies, and More January 25, 2022 • Allergy / Immunology Jeremy Rock, PhD, @leslievosshall, and @c_gaebler of @RockefellerUniv discuss #infectiousdiseases, #diseasespread, and #protection.
2:12 Well Tolerated in Preliminary Study: Pembrolizumab + TKIs in CML Patients With Persistent Detectible MRD January 19, 2022 • CML Content Hub @Dr_AmerZeidan, of @Yale, discusses #safety of #pembrolizumab plus #TKIs in #CML.
3:06 How the Pharma Industry is Accelerating Innovation January 18, 2022 • COVID-19 Chris Schott, of @JPMorgan, discusses #pharmaceutical #innovations in 2022.
